Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Choriogonadotropin alfa
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ovitrelle 250micrograms/0.5ml inj pre-filled pens
0605010X0BBACAC
|
Ovitrelle | Choriogonadotropin alfa | Endocrine System | 19 |
|
Ovitrelle 250micrograms/0.5ml inj pre-filled syringes
0605010X0BBABAB
|
Ovitrelle | Choriogonadotropin alfa | Endocrine System | 10 |
|
Choriogonadotropin alfa 250microg/0.5ml inj pf dispos dev
0605010X0AAACAC
|
Choriogonadotropin alfa | Choriogonadotropin alfa | Endocrine System | 3 |
|
Choriogonadotropin alfa 250microgram inj vials
0605010X0AAAAAA
|
Choriogonadotropin alfa | Choriogonadotropin alfa | Endocrine System | No data available |
|
Choriogonadotropin alfa 250micrograms/0.5ml inj pfs
0605010X0AAABAB
|
Choriogonadotropin alfa | Choriogonadotropin alfa | Endocrine System | No data available |
|
Ovitrelle 250microgram inj vials
0605010X0BBAAAA
|
Ovitrelle | Choriogonadotropin alfa | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.